Status
Conditions
Treatments
About
The present study was designed to observe the effectiveness of artificial intelligent based mHealth system(Chronic disease management system) to reduce bleeding events in ACS patients undergoing PCI.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
age≥18 years, male or female; confirmed acute coronary syndrome patients; undergo percutaneous coronary intervention (PCI) treatment; good command of smart phones agree to participate in this clinical study and sign a written consent form.
Exclusion criteria
ACS admission deemed secondary to other cause such as traffic accidents, trauma, severe upper gastrointestinal bleeding, surgery, or procedure; patients who are not intend to attend 1 year of follow-up study or investigators find that patients are not able to comply with the study's requirements; pregnant women or lactating women; investigators consider patients who were not suitable for participation with other reasons
Primary purpose
Allocation
Interventional model
Masking
420 participants in 2 patient groups
Loading...
Central trial contact
Yundai Chen, Master; Dandan Li, Master
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal